Epithelial Cell Adhesion Molecule
Showing 1 - 25 of >10,000
Epithelial Cell Adhesion Molecule in Epithelial Ovarian
Recruiting
- Ovarian Carcinoma
-
Sohag, Egypt
- +1 more
Oct 8, 2022
Epithelial-Mesenchymal Transition Associated Markers in
Recruiting
- Peri-implantitis
-
Karbala, IraqTalib A. Alnajaty
Apr 14, 2023
Determination of Blood Tumor Cells
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Abnormalities Cell Epithelial
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 9, 2023
Periodontitis Trial in Minya (RGD Peptide)
Completed
- Periodontitis
- RGD Peptide
-
Minya, Egypt
- +1 more
Dec 7, 2022
Intrauterine Adhesion Trial in Hangzhou (hAESCs)
Recruiting
- Intrauterine Adhesion
- hAESCs
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Oct 25, 2020
Epithelial Mesenchymal Transition and Periodontitis
Recruiting
- Periodontitis
- +5 more
- Modified Widman flap
- Gingivectomy
-
Baghdad, IraqCollege of Dentistry, University of Baghdad
May 30, 2022
Infiltrating Duct Carcinoma of the Breast
Not yet recruiting
- Invasive Breast Cancer
- (no location specified)
Jan 28, 2023
Obesity, Abdominal Obesity, Metabolic Syndrome Trial in Surabaya (Nur Aisiyah Widjaja)
Completed
- Obesity
- +6 more
- Nur Aisiyah Widjaja
-
Surabaya, East Java, IndonesiaInstitute of Tropical Disease (ITD) Airlangga University, Campus
Jan 6, 2023
Inflammation, Vaccine, Intestinal Permeability Trial in Davis (Inulin, Maltodextrin, Ty21a Typhoid Fever Vaccine)
Recruiting
- Inflammation
- +3 more
- Inulin
- +2 more
-
Davis, CaliforniaUSDA, ARS, Western Human Nutrition Research Center
Nov 29, 2022
Airway Remodeling and Rhinovirus in Asthmatics
Recruiting
- Asthma
- Respiratory Disease
- HRV-39
-
Calgary, Alberta, CanadaUniversity of Calgary
Mar 7, 2023
Prostate Cancer Trial in Madison (Docetaxel, Degarelix, Bicalutamide)
Completed
- Prostate Cancer
- Docetaxel
- +3 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Sep 12, 2022
Hiatal Hernia and Pulmonary Involvement
Active, not recruiting
- Hiatal Hernia
- Interstitial Lung Disease
- Blood Collection
- Bronchoscopy
-
Charlottesville, VirginiaUniversity of Virginia
Jan 27, 2023
Urinary Bladder Tumors Trial run by the NCI (Durvalumab, Vicineum)
Recruiting
- Urinary Bladder Neoplasms
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8, Clinical Stage IA Cutaneous Melanoma
Recruiting
- Clinical Stage 0 Cutaneous Melanoma AJCC v8
- +43 more
- Best Practice
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 12, 2022
Epithelial Ovarian Cancer, NSCLC, Renal Cell Carcinoma Trial in Saint Louis, New York (ITIL-306)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- ITIL-306
-
Saint Louis, Missouri
- +1 more
Aug 15, 2022
Non-Muscle Invasive Bladder Cancer Trial in Shanghai (VB4-845 Injection)
Recruiting
- Non-Muscle Invasive Bladder Cancer
- VB4-845 Injection
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 21, 2021
SOX17 and E-Cadherin in Variable Endometrial Lesions
Not yet recruiting
- Variable Endometrial Lesions
-
Sohag, EgyptSohag faculty of Medicine
Nov 9, 2023
Vitiligo Trial in Cairo (Narrow band UVB)
Active, not recruiting
- Vitiligo
- Narrow band UVB
-
Cairo, El Manial, EgyptKasr El Ainy university hospital, Faulty of medicine,Cairo unive
Mar 10, 2022
NSCLC Trial in United States (erlotinib, bemcentinib)
Completed
- Non-Small Cell Lung Cancer
-
Los Angeles, California
- +9 more
Aug 16, 2022
Tumors Trial in Beijing ([68Ga]N188)
Recruiting
- Neoplasms
-
Beijing, Beijing, ChinaPeking University First Hospital
Jan 27, 2023
Colorectal Cancer Trial (Characterization of tumor tissue by fluorescence)
Withdrawn
- Colorectal Cancer
- Characterization of tumor tissue by fluorescence
- (no location specified)
Mar 28, 2022
Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)
Active, not recruiting
- Colorectal Cancer
- Obinutuzumab
- +3 more
-
Los Angeles, California
- +12 more
Aug 19, 2022
Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer Trial in Shanghai (SHR-1210, Famitinib)
Recruiting
- Renal Cell Carcinoma
- +4 more
- SHR-1210
- Famitinib
-
Shanghai, Shanghai, ChinaHuadong Hospital Affiliated to Fudan University
Jun 30, 2022
Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)
Recruiting
- Extranodal NK T Cell Lymphoma
- NK-Cell Leukemia
- Anti-CD56 CAR T
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023